Bohorquez

Diego Bohórquez, PhD, associate professor in medicine, has become known as a “gut-brain neuroscientist.” His team has shown that neuropod cells, a type of sensor cell in the gut, communicate with the brain and help influence decision making about food. This work opens up the possibility of targeting the gut to treat mental health disorders and has been recognized by the U.S. National Academy of Sciences, the office of the Director of the National Institutes of Health (NIH), the New Yorker, and more. 

Petri Dish

Finding a way to slow or even stop Alzheimer’s disease is one of the most difficult challenges facing medicine today. Many research and clinical trials have led to promising results over the years, while others have produced disappointing findings. But what if there were a way to get more out of these trials—even the ones with less-than-promising results? What if there were a better way to determine if a drug is hitting its intended target?

Retina

For patients who find themselves slowly beginning to lose vision, today’s doctors have gene replacement therapy as a treatment option. However, there’s a small window of time when the therapy will work best, meaning if a patient isn’t seen soon enough, vision cannot be restored.

Easton Sinnamon

In 2021, a baby boy named Easton Sinnamon was the first person in the world to receive a combination heart transplant and allogeneic processed thymus tissue implantation. Six months later, a video showed Easton smiling and playing in a high chair, and tests indicated that the processed thymus tissue was working: building the T cells needed for a well-functioning immune system.

Subscribe to